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Background
Cancer gene expression profiling is an indispensable tool
for identifying drivers of tumor progression, identifying
subtypes, and predicting clinical outcome. An outstand-
ing challenge faced by cancer gene expression studies is
the limited concordance between studies [1], driven in
part by lack of statistical power [2]. Part of this lack of
statistical power is due to the fact that tumor samples
from some solid cancers contain between 30%-70%
healthy tissue [3]. This healthy tissue contaminates
tumor expression profiles and variable amounts of
healthy tissue leads to increased variability between
tumor expression profiles. Physical purification of these
tumor samples before profiling is often not feasible.
Materials and methods
We have developed ISOpure [4], a computational
method to purify tumor gene expression profiles using
reference samples of healthy tissue to model the contri-
bution of healthy tissue. For every tumor expression
profile in the input, ISOpure estimates the percentage of
cancerous tissue and outputs a purified cancer expres-
sion profile from which the impact of healthy tissue has
been removed. We verified our purification procedure
by measuring the performance of expression-based pre-
dictive models of patient outcome in cancer, using
either the original or ISOpure-purified expression pro-
files. We predicted extraprostatic extension (EPE) in 89
prostate tumor samples and patient survival for a set of
443 lung cancer patients.
Results and conclusions
Purified expression profiles showed significant improve-
ments in prognostic model performance. 93% of the
EPE classifiers constructed using the purified profiles
had higher accuracy on held-out data in cross-validation
than the matching classifier trained using the original
expression data (p = 1.58x10-77), with an average
improvement of 11% in performance (Fig. 1). For lung
cancer, the prognostic model based on the purified pro-
files improved hazard modeling by 39% over the model
based on the unpurified profiles (p = 0.016).
We have demonstrated that ISOpure improves our
ability to predict patient phenotype based on gene
expression, and expect to see similar improvements for
other cancer gene expression analyses such as subtype
identification and classification. We are currently gener-
ating a compendium of purified gene expression profiles
from 1600 tumor samples representing 15 different
types of solid cancer using archival data from GEO. We
are excited to work with the community at large to gen-
erate a resource of computationally purified cancer
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Figure 1 Density estimate of EPE classifier accuracy using purified
and original expression profiles.
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